Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Revolutionary inverter technology leads the clean energy charge (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CardioComm Solutions Inc V.EKG

Alternate Symbol(s):  EKGGF

Healthcare Medical Devices
CardioComm Solutions, Inc. is a global medical provider of consumer heart monitoring and medical electrocardiogram (ECG) software solutions. The Company’s technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. It develops advanced software, hardware and core laboratory reading services related to ECG and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. The Company is also engaged in manufacturing, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It has developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.


TSXV:EKG - Post by User

CardioComm Solutions Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by DabbleSnackson Apr 25, 2017 11:31am
99 Views
Post# 26162587

RE:RE:RE:EKG.V has a FDA approved device PRICE TARGET 1 DOLLAR!

RE:RE:RE:EKG.V has a FDA approved device PRICE TARGET 1 DOLLAR!
They company got FDA approval back in 2014. Look at how the stock price has trended since then. Their FDA approval is not new, shocking news and they are facing some unpleasant competition from a company partnered with Google. So calm down a little and wait to see how things play out.

EKG has some really good innovation. This new partnership will open up more markets hopefully quite significantly — the CEO has said they are moving into their sales and revenue stage. This is all great news, but slobbering on about their FDA approval as if they just scored something today is distracting and a bit misleading for new entrants.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities